Concepedia

Vishnu Nayak Badavath

VN

Statistics

Publications

35

Citations

998

H-Index

20

Active since

2014

Affiliations

Birla Institute of Technology, Mesra(Current)

Chulalongkorn University

Hebrew University of Jerusalem

Narsee Monjee Institute of Management Studies

King Chulalongkorn Memorial Hospital

Vishnu Nayak Badavath is an author at Birla Institute of Technology, Mesra specializing in pharmacology, medicinal chemistry, and pharmacy.

ORCID

Publications per year

2014–2024

35

Publications

35

Kobophenol A Inhibits Binding of Host ACE2 Receptor with Spike RBD Domain of SARS-CoV-2, a Lead Compound for Blocking COVID-19

Suresh Gangadevi, Vishnu Nayak Badavath, Abhishek Thakur et al. · The Journal of Physical Chemistry Letters · 2021 · 97 citations

, , +17

Monoamine Oxidase Inhibitory Activity of Novel Pyrazoline Analogues: Curcumin Based Design and Synthesis

Vishnu Nayak Badavath, İpek Baysal, Gülberk Uçar et al. · ACS Medicinal Chemistry Letters · 2015 · 59 citations · Full text

, , +17

High prevalence of mgrB-mediated colistin resistance among carbapenem-resistant Klebsiella pneumoniae is associated with biofilm formation, and can be overcome by colistin-EDTA combination therapy

Aye Mya Sithu Shein, Dhammika Leshan Wannigama, Paul G. Higgins et al. · Scientific Reports · 2022 · 53 citations · Full text

, , +17

Determination of potential inhibitors based on isatin derivatives against SARS-CoV-2 main protease (m<sup>pro</sup>): a molecular docking, molecular dynamics and structure-activity relationship studies

Vishnu Nayak Badavath, Akhil Kumar, Pralok K. Samanta et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 52 citations · Full text

, , +17

Design, synthesis, optimization and antiviral activity of a class of hybrid dengue virus E protein inhibitors

Surender Singh Jadav, Suzanne J. F. Kaptein, Ajaykumar Timiri et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 49 citations · Full text

, , +11

1–5 of 35